edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

Eli Lilly Advances on Positive Drug Trial Results and Regulatory Designations
Stock NewsThemesEli Lilly Advances on Positive Drug Trial Results and Regulatory Designations

Eli Lilly Advances on Positive Drug Trial Results and Regulatory Designations

Edgen StockEdgen Stock·Sep 12 2025, 00:19
Share to
Share to
Copy link
LLYLLY+1.43%MRKMRK+0.36%
Eli Lilly Advances on Positive Drug Trial Results and Regulatory Designations
source:
[1] Eli Lilly (LLY) Announces Promising Results For Jaypirca In CLL Phase 3 Trial (https://finance.yahoo.com/news/eli-lilly-lly- ...)[2] Eli Lilly (LLY) Reports Promising Results from BRUIN CLL-313 Clinical Trial - GuruFocus (https://www.gurufocus.com/news/20250908/eli-l ...)[3] Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Sept 2025) (https://vertexaisearch.cloud.google.com/groun ...)

Related News

Babcock & Wilcox Secures $40M Refinery Contract
Dec 19 2025, 22:38

Babcock & Wilcox Secures $40M Refinery Contract

Babcock & Wilcox announced on December 19, 2025, that it secured a $40 million contract to supply its Wet Gas Scrubbing technology to a Canadian petroleum refinery, major Canadian petroleum refinery.

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales
Dec 19 2025, 22:29

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

A Yale study finds Elon Musk's political stance cost Tesla 1.26 million car sales, contributing to a profit drop to $7.1 billion in 2024 from $15 billion in 2023.

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes
Dec 19 2025, 22:27

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes

On December 16, Mizuho increased its price target for Tesla to $530, citing growing confidence in the automaker's future robotaxi business.